A phase 1 clinical trial evaluating SIM0335 for the treatment of psoriasis
Latest Information Update: 30 Jun 2022
At a glance
- Drugs SIM 0335 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
Most Recent Events
- 27 May 2022 Status changed from recruiting to completed, according to a Simcere Pharmaceutical Group media release.
- 25 Apr 2022 New trial record